These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12719885)

  • 1. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study.
    Levin MD; de Veld JC; van der Holt B; van 't Veer MB
    Ann Hematol; 2003 Jun; 82(6):357-62. PubMed ID: 12719885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
    Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
    Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
    Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].
    Barz D; Staack D; Lehmann R; Stange K; Schnurstein K
    Beitr Infusionsther Transfusionsmed; 1996; 33():30-4. PubMed ID: 8974705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury.
    Pereboom IT; de Boer MT; Haagsma EB; Hendriks HG; Lisman T; Porte RJ
    Anesth Analg; 2009 Apr; 108(4):1083-91. PubMed ID: 19299765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocyte substitution in hematologic patients].
    Wiesneth M
    Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
    Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
    Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for alloantibodies in the serum of patients receiving platelet transfusions: a comparison of the ELISA, lymphocytotoxicity, and the indirect immunofluorescence method.
    Levin MD; de Veld JC; van der Holt B; van't Veer MB
    Transfusion; 2003 Jan; 43(1):72-7. PubMed ID: 12519433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
    Sandler SG
    Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
    Barz D; Gatzka E; Kollmorgen I
    Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy.
    Chaoui D; Chakroun T; Robert F; Rio B; Belhocine R; Legrand O; Salanoubat C; Lecrubier C; Casadevall N; Marie JP; Elalamy I
    Transfusion; 2005 May; 45(5):766-72. PubMed ID: 15847667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
    Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
    Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia.
    Apelseth TO; Hervig T; Wentzel-Larsen T; Petersen K; Reikvam H; Bruserud Ø
    Eur Cytokine Netw; 2011 Mar; 22(1):52-62. PubMed ID: 21388914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and product factors affecting platelet transfusion results.
    Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
    Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients.
    Thomas L; Kaidomar S; Kerob-Bauchet B; Moravie V; Brouste Y; King JP; Schmitt S; Besnier F; Abel S; Mehdaoui H; Plumelle Y; Najioullah F; Fonteau C; Richard P; Césaire R; Cabié A
    Transfusion; 2009 Jul; 49(7):1400-11. PubMed ID: 19320862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical impact of platelet refractoriness: correlation with bleeding and survival.
    Kerkhoffs JL; Eikenboom JC; van de Watering LM; van Wordragen-Vlaswinkel RJ; Wijermans PW; Brand A
    Transfusion; 2008 Sep; 48(9):1959-65. PubMed ID: 18564396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.